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Abstract Motion artifacts are a well-known and frequent
limitation during neuroimaging workup of cognitive decline.
While head motion typically deteriorates image quality, we
test the hypothesis that head motion differs systematically
between healthy controls (HC), amnestic mild cognitive
impairment (aMCI) and Alzheimer disease (AD) and con-
sequently might contain diagnostic information. This pro-
spective study was approved by the local ethics committee
and includes 28 HC (age 71.0 ± 6.9 years, 18 females), 15
aMCI (age 67.7 ± 10.9 years, 9 females) and 20 AD (age
73.4 ± 6.8 years, 10 females). Functional magnetic reso-
nance imaging (fMRI) at 3T included a 9 min echo-planar
imaging sequence with 180 repetitions. Cumulative average
head rotation and translation was estimated based on stan-
dard fMRI preprocessing and compared between groups
using receiver operating characteristic statistics. Global
cumulative head rotation discriminated aMCI from controls
[p \ 0.01, area under curve (AUC) 0.74] and AD from
controls (p \ 0.01, AUC 0.73). The ratio of rotation z versus
y discriminated AD from controls (p \ 0.05, AUC 0.71) and
AD from aMCI (p \ 0.05, AUC of 0.75). Head motion
systematically differs between aMCI/AD and controls. Since
motion is not random but convoluted with diagnosis, the
higher amount of motion in aMCI and AD as compared to
controls might be a potential confounding factor for fMRI
group comparisons. Additionally, head motion not only
deteriorates image quality, yet also contains useful dis-
criminatory information and is available for free as a ‘‘side
product’’ of fMRI data preprocessing.
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aMCI Amnestic mild cognitive impairment
AUC Area under the curve
fMRI Functional magnetic resonance imaging
HC Healthy control
MMS Mini mental state
MRI Magnetic resonance imaging
PET Positron emission tomography
rs-fMRI Resting-state fMRI
ROC Receiver operating characteristic
Introduction
Head motion related artifacts are a well-known and fre-
quent problem in the neuroimaging workup of cognitive
decline deteriorating image quality (Ikari et al. 2012;
Sperling 2011). We assessed whether head motion sys-
tematically differs between amnestic mild cognitive
impairment (aMCI) and Alzheimer disease (AD) patients
as compared to healthy controls (HC). A potential sys-
tematic difference in head motion between groups would in
turn imply that head motion does not only deteriorate
image quality, but may actually contain useful discrimi-
natory information.
The early detection of Alzheimer disease (AD) and in
particular amnestic mild cognitive impairment (aMCI) is a
key clinical question, as promising therapeutic candidates
are currently being evaluated (for review see (Nitsch and
Hock 2008; Duara et al. 2009)). Recent studies indicate a
limited performance of these therapeutic candidates in
patients with clinically overt dementia (Holmes et al. 2008;
Lannfelt et al. 2008). This implies a need for early treat-
ment, which in turn implies a need for early diagnosis.
Mild cognitive impairment (MCI) represents a transition
zone between normal aging and very early dementia and is
characterized by selective memory deficits associated or
not with other cognitive dysfunctions (Petersen and Negash
2008). The definitions of MCI have substantially evolved
and changed over the last years, which goes beyond the
scope of this manuscript. We specifically focus on amnestic
MCI (aMCI), which is the most likely MCI subgroup to
eventually progress to clinically overt AD with an annual
rate of 10–15 % (Petersen 2004; Mariani et al. 2007),
whereas other MCI subgroups may remain stable or evolve
to other forms of dementia (Forlenza et al. 2009).
Multiple recent investigations assessed the performance
of various neuroimaging techniques for the early detection
of AD and MCI, including T1 derived grey matter voxel
based morphometry (Plant et al. 2010; Misra et al. 2009;
Fan et al. 2008), diffusion tensor imaging (DTI) derived
white matter properties (Haller et al. 2010b, 2013;
O’Dwyer et al. 2012), susceptibility derived iron deposition
(Haller et al. 2010a) and in particular functional MRI
(Mueller et al. 2011; Fox and Greicius 2010; Sperling
2011).
Head motion parameters are routinely estimated during
the data preprocessing steps of fMRI. These parameters are
typically used as non-explanatory co-variables for the data
analysis, yet are not specifically analyzed as discriminatory
parameters. In the current investigation, we tested the
hypothesis that aMCI and AD have increased head motion
parameters compared to HC. This analysis makes use of
already existing and thus freely available motion correction
parameters of fMRI data and might complement the results
of the ‘‘actual’’ fMRI analyses.
Materials and Methods
Participants
The institutional ethical committee of the University of
Basel, Switzerland, approved this prospective study and all
participants gave written informed consent prior to inclu-
sion. The study is in agreement with the Declaration of
Helsinki. All individuals were examined as described in
detail before (Monsch and Kressig 2010). The diagnosis
criteria for AD were based on the NINCDS-ADRDA criteria
(McKhann et al. 1984). The diagnosic criteria for aMCI were
based on the criteria by Winblad et al. (2004). Healthy
controls were recruited from the Basel Study on the Elderly.
They essentially underwent the same procedure as described
above (Monsch and Kressig 2010). The local memory clinic
prospectively and consecutively included 63 participants.
MR Imaging
MR imaging was performed on a 3T clinical routine whole
body MRI scanner (Verio, Siemens Medical Systems Er-
langen, Germany). Standard routine clinical imaging
included a 3DT1w (1mm3 isometric, 256 9 256 9 176
matrix), DTI (30 directions, b 1000). Additional sequences
(T1w, T2w, T2*, FLAIR) were acquired and analyzed to
exclude brain pathology such as ischemic stroke, subdural
hematomas or space-occupying lesions. T2 lesions were
analyzed using a simple visual rating scale of Fazekas
(Fazekas et al. 1987).
The 9 min fMRI echo planar imaging (EPI) scan cov-
ering the entire brain was acquired with the following
parameters: 64 9 48 matrix, 34 slices, voxel size
3.44 9 3.44 9 3.5 mm3, TE 12.3, 29.5, 46.8 and 64 ms,
TR 2,970 ms, 180 repetitions.
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MR Data Analysis
Data was preprocessed using standard parameters in SPM8.
All functional images were motion-corrected via realign-
ment to the mean image. The absolute values of the
instantaneous differences between motion correction
parameters for translation (X, Y and Z) and rotation (pitch
X, roll Y and yaw Z) were computed and summed across
the entire functional run per participant, yielding total
instantaneous translation in mm for the three translations
and radians for the three rotations. In the following, we
consider cumulative head motion parameters (i.e. the sum
of head motion over the 9 min acquisition time) for head
rotation (x,y,z) and head translation (x,y,z).
Statistical Analysis
Statistical analysis was performed in Graphpad Prism,
Version 5.0 (www.graphpad.com).
Results
Demographic and Clinical Data
We included 28 HC (age 71.0 ± 6.9 years, 18 females,
mini mental state MMS 29.2 ± 1.0), 15 aMCI (age
67.7 ± 10.9 years, 9 females, MMS 27.8 ± 1.5) and 20
AD (age 73.4 ± 6.8 years, 10 females, 24.6 ± 3.1). There
was no significant difference in age (parametric ANOVA)
or gender (non-parametric Kruskal–Wallis test) between
groups. Likewise, there was no significant difference (non-
parametric Kruskal–Wallis test) between groups with
respect to (Fazekas et al. 1987) T2 lesions score (HC
1.2 ± 0.9, aMCI 1.1 ± 0.8, AD 1.2 ± 0.9).
In contrast, there was a significant group difference in
the MMS (analysis of variance ANOVA p \ 0.0001), with
significant Bonferroni corrected pair-wise differences
between HC versus AD (p \ 0.0001) and aMCI versus AD
(p \ 0.0001).
Motion Correction Parameters
Concerning global accumulated head rotation (Fig. 1), the
data did not fulfill the assumption of normal distribution
(Shapiro–Wilk normality test) and were thus analyzed
using non-parametric Kruskal–Wallis group comparisons
and pair-wise Dunn’s multiple comparisons tests. There
was a significant group difference (p \ 0.001) as well as
significant pair-wise differences between aMCI versus HC
(p \ 0.05) and AD versus HC (p \ 0.05), as illustrated in
Fig. 2a. Receiver operator characteristics (ROC) signifi-
cantly discriminated (p \ 0.01) aMCI versus HC with an
area under the curve (AUC) of 0.74 (Fig. 3a), as well as
AD versus HC (p \ 0.01), AUC 0.73 (Fig. 3b). In contrast,
there was no significant difference between aMCI versus
AD in accumulated rotation.
Concerning head translation (Fig. 1b), the data did not
fulfill the assumption of normal distribution (Shapiro–Wilk
normality test). There were equivalent trends as compared
to head rotation (p = 0.06), yet no significant differences
(Fig. 3b).
AD patients had in particular strong rotation along the
z-axis (yaw), i.e. rotating the head in a left–right direction
like saying ‘‘no’’. We calculated the ratio of z-rotation
‘‘no’’ versus y-rotation (roll, or tilting the head to both
sides), as a within-subject normalization (Fig. 2c). These
data fulfilled the criteria of normal distribution (Shapiro–
Wilk normality test) and were analyzed using parametric
analysis of variance (ANOVA) group comparisons and
pair-wise Bonferroni’s multiple comparison tests. There
was a significant group effect (p \ 0.01), as well as sig-
nificant differences between HC versus AD (p \ 0.05) and
between aMCI versus AD (p \ 0.05).
ROC significantly discriminated (p \ 0.05) HC versus
AD with an AUC of 0.71 (Fig. 4b) and aMCI versus AD
(p \ 0.05) with an AUC of 0.75. In contrast, this parameter
did not discriminate HC versus aMCI.
Discussion
The current investigation is based on the observation that
head motion artifacts are very common during the neuro-
imaging workup of neurocognitive decline (Ikari et al.
2012). In agreement with our hypothesis, global head
motion was more pronounced in patients and discriminated
aMCI and AD from controls. Consequently, head motion
not only deteriorates image quality, yet also contains useful
discriminatory information. Head motion parameters are
routinely estimated during the data processing of fMRI
studies (Fox and Greicius 2010), available for free as a
‘‘side product’’ and might complement existing tests to
discriminated AD and aMCI from controls. The simple
global accumulated head rotation significantly (p \ 0.01)
discriminated aMCI versus HC with an area under the
curve (AUC) of 0.74 as well as AD versus controls
(p \ 0.01, AUC 0.73).
The major point of this paper is to demonstrate that head
motion not only deteriorates image quality in a random
fashion, but rather is convoluted in a systematic fashion
with clinical diagnosis. The main strength of the current
investigation is the use of the ‘‘freely available’’ motion
parameter in fMRI to discriminate aMCI and AD from
controls. The simple parameter of accumulated global head
rotation discriminated aMCI and AD from controls.
Brain Topogr (2014) 27:801–807 803
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Although these motion parameters are routinely estimated
during data processing of fMRI data, these parameters are
typically not specifically analyzed. Given this systematic
effect, adding motion parameters as an additional covariate
in the analysis of fMRI data may be prudent.
Our observation of increased head motion in aMCI and
AD in fMRI is in agreement with previous experience in
the field of fMRI (Sperling 2011) and positron emission
tomography (PET) scans, for example in the Japanese
Alzheimer disease neuroimaging initiative (J-ADNI) multi-
center study (Ikari et al. 2012). Interestingly, a recent
investigation demonstrated that head motion produces
substantial resting-state fMRI changes despite compensa-
tory spatial registration and regression of motion estimates
(Power et al. 2012). In particular, long-distance correla-
tions are decreased while short-distance correlations are
Fig. 1 Average head rotation (a) and translation (b) and standard deviations (black lines) for HC (green), aMCI (blue) and AD (red) separated
for x, y, z and average across all 3 axes (Color figure online)
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increased by head motion. As we observed systematic
difference in the amplitude of head motion between the
study groups, this implies that group differences in head
motion might actually represent a systematic confound for
rs-fMRI connectivity studies between controls, MCI and
AD subjects.
Due to the spatial constraints of the MRI table and the
head coil, some head motions are easier than others. In
particular, rotatory movements to the left and right (yaw,
like saying ‘‘no’’) and rotation up and down (pitch, like
saying ‘‘yes’’) are relatively easy, while left—right tilting
movements (roll, inclining the head sideways) or
Fig. 2 Illustrates the group average head motion parameters for
rotation (a), translation (b) as well as the ratio of yaw (rotation z)
versus roll (rotation y) in (c). Head rotation discriminated aMCI
(blue) from HC (green, p \ 0.05) and AD (red) from HC (p \ 0.05).
The ration of yaw/roll discriminated AD from HC (p \ 0.05) and AD
from aMCI (p \ 0.05) (Color figure online)
Fig. 3 The receiver operator characteristics (ROC) analysis of the head rotation discriminated aMCI from HC (p \ 0.01, a) and AD from HC
(p \ 0.01, b), while there was no significant difference between aMCI and AD (c)
Fig. 4 The ROC analysis of the ratio of yaw/roll discriminated AD versus HC (p \ 0.05, b) and AD versus aMCI (p \ 0.05, c) but not HC
versus aMCI (a)
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longitudinal translation movements are more restricted. In
agreement with these spatial constraints, rotation move-
ments were more pronounced than linear translation
movements in our data. As discussed above, the discrimi-
nation between aMCI versus controls is the clinically most
relevant parameter. Concerning the discrimination of AD
versus controls, the clinical diagnosis is oftentimes already
established in this advanced stage of the disease. The dis-
crimination between aMCI and AD was less evident in the
current data as both groups show considerable head
motion. In our sample, AD patients performed in particular
strong motion along the Z axis, i.e. right-left rotation of the
head or ‘‘no’’ movements. To relatively normalize this
‘‘no’’ motion per subject, we calculated the ratio between Z
rotation versus Y rotation (roll or tilting the head side-
ways). This parameter discriminated AD patients from
controls (p \ 0.05) as well as from aMCI (p \ 0.05).
Limitations
Major limitations of the current investigations include the
relatively small sample sizes per group, which is due to the
strict pre-selection of patients in a single-center study. Our
results should thus be confirmed in larger scale studies.
Moreover, the current investigation deliberately assessed
basic and simple global head movement. The exact origin
of the head motions are not assessed in detail in the current
investigation and may include decreased compliance,
increased anxiety, loss of fine motor coordination and other
factors. Future studies might determine whether more
detailed motion derived parameters such as speed of
acceleration/deceleration or frequency of oscillations may
also discriminate between different diseases, for example
other forms of dementia such as frontotemoral lobar
degeneration or other neurodegenerative diseases such as
Parkinson Disease taking into account that head motion
might be influenced by multiple factors including for
example medication.
Conclusions
The higher amount of motion in aMCI and AD as com-
pared to controls might be a potential confounding factor in
fMRI group comparisons. Moreover, head motion during
functional imaging of cognitive decline not only deterio-
rates image quality but also contains useful discriminatory
information. Motion correction parameters are available for
free as ‘‘side product’’ during the data preprocessing in
fMRI studies and may complement other parameters to
discriminate aMCI and AD from controls. More detailed
motion parameters might contain specific information in
various diseases, which remains to be elucidated in larger
scale studies.
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